Human Cloning: Are the Ultra-Wealthy Engaging in Secret Experiments?

Is it conceivable that the ultra-wealthy are covertly cloning humans?

Juan Lovaro/Shutterstock

Throughout my extensive career reporting on extraordinary breakthroughs in biology, I’ve observed numerous concepts gaining massive attention, receiving thorough media scrutiny for years, and later fading from the public consciousness. Take, for instance, human cloning.

Following the landmark birth of Dolly the sheep in 1997—the first cloned mammal—speculation soared about the potential for human cloning. There were even some implausible claims about human clones existing. Yet, in recent years, such fervor has significantly diminished.

Nonetheless, reproductive technologies have evolved remarkably since the 1990s. Notably, just six years after CRISPR was unveiled, the world saw the first unlawful creation of a gene-edited child. This raises questions about what might be occurring behind closed doors. Are human clones already out there, undetected? Of course, identical twins don’t count.

What could motivate someone to engage in this? Recently, in a discussion between Vladimir Putin and Xi Jinping, the topic of extending life via organ transplants emerged. The most effective method could involve cloning individuals for organ harvesting, thereby eliminating the common issue of immune rejection often depicted in science fiction narratives. Consider Island or the book Never Let Me Go.

Moreover, cloning brings forth the notion of creating a duplicate of a person, offering a semblance of immortality, as illustrated in the television series Foundation, where the empire is governed by successive clones. However, our experiences with identical twins tell us that sharing the same genome does not equate to being the same person. As shown by Tatiana Maslany in the series Orphan Black, each clone evolves into a distinct individual. Nevertheless, wealthy individuals can hold irrational beliefs similar to others and often display a particular desire to extend their lifespans.

For scientists, there’s also the allure of being the first to achieve a groundbreaking feat. A report from a Chinese commission determined that the creators of CRISPR children “conducted research illegally in pursuit of personal fame and profit.”

Goals of Therapeutic Cloning

So, could human clones exist? For many years, the notion of cloning mammals was deemed unfeasible. Early embryo cells have the ability to differentiate into any bodily part but quickly become specialized—a process previously thought irreversible.

Dolly’s existence disproved that theory. She was produced by fusing cells from an adult ewe’s udder with a DNA-depleted egg. Her announcement in February 1997 led to a frenzy of attempts to generate cloned human embryos. The objective wasn’t to create cloned infants, but rather to harvest embryonic stem cells for novel medical therapies. As cloned cells are a perfect match for an individual, they could theoretically be employed to produce replacement tissues and organs with no risk of immune rejection.

However, extracting stem cells from cloned human embryos has proven more challenging than anticipated. It wasn’t until 2004 that Hwang Woo-seok claimed success. At that time, I found his paper impressive, as it addressed all conceivable objections effectively. Unfortunately, the study was later revealed to be fraudulent, resulting in its retraction. This experience remains ingrained in my memory. Nowadays, whenever a thesis appears too good to be true, my initial instinct is to be skeptical.

Ultimately, true embryonic stem cells from cloned human embryos weren’t obtained until 2013. By then, alternative methods for generating compatible stem cells through the activation of specific genes had emerged, leading to a decline in interest in therapeutic cloning.

Cloned Pets and Other Animals

Conversely, animal cloning has become increasingly established. Occasionally, headlines emerge when celebrities disclose that they’ve cloned their pets. Recently, former NFL player Tom Brady made news by revealing that his dog is a clone, produced by a company acquired by Colossal Biosciences.

Apart from serving as a way to “revive” cherished pets, cloning is also utilized in agriculture and horse breeding. For instance, male horses are often castrated, meaning that if they excel in show jumping, the only method to utilize their genetic material for future breeding is through cloning.

Nonetheless, animal cloning continues to pose significant challenges. A 2022 study of the first 1000 dog clones found that the cloning process is still highly inefficient, with merely 2 percent of implanted cloned embryos resulting in live births. This inefficiency contributes to the high cost of pet cloning, around $50,000.

Moreover, about 20% of cloned dogs presented noticeable physical anomalies, including enlarged tongues, unusual eye colors, cleft palates, and excessive muscle mass. Some male dog clones even exhibited female physical traits.

But what if the wealthy and powerful could clone themselves, unburdened by such concerns?

Challenges in Adult Cloning

Multiple sources have indicated several successful monkey cloning endeavors since 2017, suggesting potential applicability for humans as well. However, these sources often fail to mention that all these primate clones have been derived from fetal cells, not adult ones.

The crux of the issue lies in the fact that reprogramming adult cells to mimic a fetal state is far more complex than reprogramming fetal cells. To me, cloning signifies creating a genetically identical replica of an adult, which is what made Dolly’s achievement exceptional.

In essence, I remain convinced that cloning an adult is still unattainable. In a world filled with dictators and eccentric billionaires, this might be a fortunate circumstance.

topic:

Source: www.newscientist.com

OpenAI warns against releasing voice cloning tools due to safety concerns.

OpenAI’s latest tool can create an accurate replica of someone’s voice with just 15 seconds of recorded audio. This technology is being used by AI Labs to address the threat of misinformation during a critical global election year. However, due to the risks involved, it is not being released to the public in an effort to limit potential harm.

Voice Engine was initially developed in 2022 and was initially integrated into ChatGPT for text-to-speech functionality. Despite its capabilities, OpenAI has refrained from publicizing it extensively, taking a cautious approach towards its broader release.

Through discussions and testing, OpenAI aims to make informed decisions about the responsible use of synthetic speech technology. Selected partners have access to incorporate the technology into their applications and products after careful consideration.

Various partners, like Age of Learning and HeyGen, are utilizing the technology for educational and storytelling purposes. It enables the creation of translated content while maintaining the original speaker’s accent and voice characteristics.

OpenAI showcased a study where the technology helped a person regain their lost voice due to a medical condition. Despite its potential, OpenAI is previewing the technology rather than widely releasing it to help society adapt to the challenges of advanced generative models.

OpenAI emphasizes the importance of protecting individual voices in AI applications and educating the public about the capabilities and limitations of AI technologies. The voice engine is watermarked to enable tracking of generated voices, with agreements in place to ensure consent from original speakers.

While OpenAI’s tools are known for their simplicity and efficiency in voice replication, competitors like Eleven Labs offer similar capabilities to the public. To address potential misuse, precautions are being taken to detect and prevent the creation of voice clones impersonating political figures in key elections.

Source: www.theguardian.com

Has the successful cloning of monkeys opened the door to human cloning?

cloned rhesus monkey

Zhaodi Liao et al.

After many years and many attempts, a healthy rhesus monkey was finally created by cloning. The clone was born in China on July 16, 2020, but its existence has only now been revealed.

“The cloned rhesus macaque is now 3 years old,” team members say Fallon Lu at the Chinese Academy of Sciences in Beijing. “So far, no health problems have been found during routine medical examinations.”

However, because the monkeys were cloned from fetal cells rather than adult cells, the embryos had to be provided with a non-cloned placenta. Therefore, despite this progress, primate cloning remains extremely difficult. As a result, apart from ethical and legal issues, it may not yet be technically possible to clone an adult.

Cloning is the creation of an individual that is genetically identical to another individual. Cloning plants is easy, but for most animals it is much more difficult.

Dolly the sheep, the first mammal cloned from an adult cell, was born in 1996. Since then, researchers have attempted to clone many mammalian species, with mixed results.

In some cases, cloning works relatively well.A Korean team created a clone over 1500 dogs For example, so far, success rates remain low, with fewer than 4 percent of cloned embryos leading to live births. In many other mammalian species, cloning either fails completely or produces unhealthy animals.

The main problem is that as cells in the body develop and become specialized, various so-called epigenetic markers are added to the DNA in order to turn certain genes on or off. When adult cells are cloned into empty eggs, they usually contain the wrong epigenetic markers.

Primates (a group that includes apes such as monkeys and humans) have proven particularly difficult to treat. There have been several previous reports of monkey clones, but each case so far has come with major warnings.

For example, the rhesus macaque born in 1999 is sometimes described as the first primate clone, but this individual was created not by cloning adult cells like Dolly, but by creating identical twins. It was created by splitting the embryo, as is done.

In 2022, rhesus macaques will be born. cloned from a genetically modified adult However, this clone died shortly after birth.

The most successful attempt to date was the birth of two long-tailed macaques in 2017. The researchers behind this study used a chemical cocktail to help reset epigenetic markers, but they were still able to clone only fetal cells, not adult cells.

Lu's team tried applying the same cocktail to rhesus macaques, but the only clone produced this way did not survive. The researchers concluded that the abnormalities in the cloned placenta were partially to blame, and decided to transplant the part of the early embryo that turns into a fetus (the inner cell mass) into a non-cloned embryo, where the inner cell mass forms. Developed new technology. Cell clumps were removed.

This means that the cloned fetus develops within a non-cloned placenta that is genetically distinct from it. Theoretically, the resulting fetuses could be a mixture of clonal and non-clonal cells, but the researchers found no evidence of such chimerism.

But even with the help of this complex technique, the researchers have so far only cloned fetal cells and not adult cells. In other words, healthy primates have not yet been created by cloning adult cells.

This means that whether it is possible to clone adults remains an open question. Lu wouldn't speculate on whether his team's technique would help.

“The act of cloning humans is completely unacceptable. We don't think about this,” he says.

Shukrat Mitalipov A professor at Oregon Health & Science University, who also works on cloning but was not involved in the study, says it's unclear whether the technology will help create cloned humans. “Aside from ethical issues, it is unclear whether there is any humanity. [cloned] “The fetus has placental abnormalities,” Mitalipov said.

Lu says the purpose of primate cloning is to advance research. “Rhesus monkeys are important and commonly used non-human primate laboratory animals in cognitive and biomedical research,” he says.

Meanwhile, Mitalipov's aim is to use cloning to generate stem cells that are compatible with individual treatments. “In our case, one day doctors will be able to use non-rejection, genetically compatible embryonic stem cells to replace diseased nerve, muscle, blood and other cells, or to produce eggs for infertility treatment. I hope we can produce it,” he says.

topic:

Source: www.newscientist.com